Hereditary neurological diseases caused by triplet repetitions;MALADIES NEUROLOGIQUES HEREDITAIRES DUES A L'AMPLIFICATION DE LA REPETITION D'UN TRIPLET

Presse Medicale

Volumn 27, Issue 8, 1998, Pages 376-381

  Warter, J M ^a   Tranchant, C ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA SEQUENCE; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENETIC COUNSELING; HUMAN; HUNTINGTON CHOREA; MUSCLE ATROPHY; MUTATION; MYOTONIC DYSTROPHY; NEUROLOGIC DISEASE; PRENATAL DIAGNOSIS; REVIEW; CLASSIFICATION; GENE AMPLIFICATION; GENETIC DISORDER; GENETIC SCREENING; GENETICS; NUCLEOTIDE SEQUENCE; TRINUCLEOTIDE REPEAT;

DNA MUTATIONAL ANALYSIS; GENE AMPLIFICATION; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; HUMANS; MUTATION; NERVOUS SYSTEM DISEASES; PRENATAL DIAGNOSIS; TRINUCLEOTIDE REPEATS;

EID: 0032574021     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Timchenko LT, Caskey CT. Trinucleotide repeat disorders in humans : discussions of mechanisms and medical issues. Faseb 1996 ; 10:1589-97.
2. Sherman SL, Jacobs PA. Morton NE et al. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 1985 ; 69:289-99.
3. Verkerk AJMH. Pieretti M, Sutcliffe JS et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibing length variation in fragile X syndrome. Cell 1991 ; 65:905-14.
4. Fu YH, Kuhl DPA. Pizzuti A et al. Variation of the CGG repeat at the fagrile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991 ; 67:1047-58.
5. Oberlé I, Boué J, Croquette MF et al. Three families with high expression of a fragile site at Xq 27.3, lack of anomalies at the FMR-1 CpG Island, and no clear phenotypic association. Am J Med Genet 1992 ; 43:224-31.
6. Moutou C, Vincent MC, Biancalana V, Mandel JL. Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum Mol Gen 1997 ; 6:971-9.
7. De Bolle K, Verkerk AJMH., Reyniers E et al. A point mutation in the FMR.1 gene associated with fragile X mental retardation. Nature Genet 1993 : 3:31-5.
8. Pieretti M. Zhang F, Fu YH et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991 ; 66:817-22.
9. Tamanini F, Meijer N, Verheij C, Willems PJ et al. FMRP is associated to the ribosomes via RNA. Hum Mol Gen 1996 ; 5:809-13.
10. Chakrabarti L, Knight SJ, Flannery A, Davies KE A candidate for mild mental handicap at the FRAXE fragile site. Hum Mol Gen 1996 ; 5:275-82.
11. Harley HG, Brook JD, Rundle SA et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992 ; 355:545-6.
12. Buxton J, Shelboume P, Davies J et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992 ; 355:547-8.
13. Aslanidis C, Jansen G, Amemiya C et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992 ; 355:548-51.
14. Brook JD, McCurrach ME, Harley HG et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992 ; 68:799-808.
15. Mahadevan M, Tsilfidis C, Sabourin L et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992 ; 255:1253-5.
16. Fu YH, Pizzuti A, Fenwick RG et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992 ; 255:1256-8.
17. Fu YH, Friedman DL, Richards S et al. Decreased expression of Myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993 ; 260:235-8.
18. O'Hoy KL, Tsilfidis C, Mahadevan MS et al. Reduction in size of the myotonic dystrophy trinucleotide repeat mutation during transmission. Science 1993 ; 259:809-12.
19. Reddy S, Smith DBJ, Rich MM et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet 1996 ; 13:325-35.
20. Harris S, Moncrieff C, Johnson K Myotonic dystrophy: will the real gene please step forward ! Hum Mol Gen 1996 ; 5:1417-23.
21. Heath SK, Carne S, Hoyle C, Johnson KJ, Wells D. Characterisation of expression of mDMAHP, a homeodomain-encoding gene at the murine DM locus. Hum Mol Gen 1997 ; 6:651-7.
22. Klesert TR, Otten AD, Bird TD, Tapscott SJ. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genet 1997 ; 16:402-6.
23. Campazzano V, Montermini L, Molto MD et al. Friedreich ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996 ; 271:1423-7.
24. Durr A, Cossee M, Agid Y et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 1996 ; 335:1169-75.
25. Babcock M, De Silva D, Oaks R et al. Regulation of mitochondrial accumulation by Yfh 1p, a putative homolog of frataxin. Science 1997 ; 276:1709-12.
26. Wilson RB, Roof DM. Respiratory deficiency due to loss of Nature mitochondrial DNA in yeast lacking the frataxin homologue. Genetics 1997 ; 16:352-7.
27. Koutnikova H, Campuzano V, Foury F, Dollé P, Cazzalini O, Koenig M. Studies of human, mouse ant yeast homologues indicate a mitochdrial function for frataxin. Nature Genet 1997 ; 16:345-51.
28. Filla A, De Michele G, Cavalcanti F et al. The relationship between trinudeotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996 ; 59:554-60.
29. Ross CA. When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 1995: 15:493-6.
30. Zeitlin S, Liu JP, Chapman D, Papaioannou VE, Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet 1995 ; 11:155-63.
31. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991 ; 352:77-9.
32. Brooks BP, Fischbeck KH. Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. TINS 1995 ; 18:459-61.
33. Zhuchenko O, Bailey J, Bonnen P et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the (1A-voltage-dependent calcium channel. Nature Genet 1997 ; 15:62-8.
34. Matsuyama Z, Kawakami H, Maruyama H et al. Molecular features of th CAG repeats of spinocerebellar ataxia 6 (SCA6). Hum Mol Gen 1997 ; 6:1283-7.
35. Riess O, Schölss L, Böttger H, Nolte D et al. SCA6 is caused by moderate CAG expansion in the α 1A-voltage-dependent calcium channel gene. Hum Mol Gen 1997 ; 6:1289-93.
36. Huntington's disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993 ; 72:971-83.
37. Sharp AH, Ross CA Neurobiology of Huntington's disease. Neurobiol Dis 1996 ; 3:3-15.
38. Yanagisawa H, Fujii K, Nagafuchi S et al. A unique origin and multistep process for the generation of expanded DRPLA triplet repeats. Hum Mol Gen 1996 ; 5:373-9.
39. Koide R, Ikeuchi T, Onodera O et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet 1994 ; 6:9-13.
40. Khan FA, Margolis RL, Loev SL, Sharp AH, Li SH, Ross C. cDNA cloning and characterization of an atrophin-1 (DRPLA disease gene)-related protein. Neurobiol Dis 1996 ; 3:121-8.
41. Orr HT, Chung M, Banfi S et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet 1993 ; 4:221-5.
42. Banfi S, Servadio A, Chung M et al. Identification and characterization fo the gene causing type 1 spinocerebellar ataxia. Nature Genet 1994 ; 7:513-14.
43. Trottier Y, Lutz Y, Stevanin G et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995 ; 378:403-6.
44. Stevanin G, Trottier Y, Cancel G et al. Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Hum Mol Gen 1996 ; 5:1887-92.
45. Sanpei K, Takano H, Igarashi S et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet 1996 ; 14:277-84.
46. Imbert C, Saudou F, Yvert G et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet 1996 ; 14:285-91.
47. Durr A, Stevanin G, Cancel G et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: dinical molecular, and neuropathological features. Ann Neurol 1996 ; 39:490-9.
48. Higgins JJ, Nee LE, Vasconcelos O et al. Mutations in american families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology 1996 ; 46:208-18.
49. Benomar A, Krols L, Stevanin G et al. The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nature Genet 1995 ; 10:84-8.
50. Gouw LG, Kaplan CD, Haines JH et al. Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nature Genet 1995 ; 10:89-93.
51. Rubinsztein DC, Leggo J, Coles R. et al. Phenotypic charecterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats. Am J Hum Genet 1996 ; 59:16-22.
52. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci 1994 ; 91:5355-8.
53. Carrell RW, Lomas DA. Conformational disease. Lancet 1997 ; 350:134-8.
54. De Rooij KE, Dorsman JC, Smoor MA, Den Dunnen JT, Van Ommen GJB. Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum Mol Gen 1996 ; 5:1093-9.
55. Gerber HP, Seipel K, Georgiev O et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 1994 ; 263:808-11.
56. Cariello L, De Cristofaro T, Zanetti L et al. Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease. Hum Genet 1996 ; 98:633-5.
57. Trottier Y, Devys D, Imbert B et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet 1995 ; 10:104-10.
58. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet 1995 ; 10:94-8.
59. Li XJ, Li Sh, Sharp AH et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995 ; 378:398-402.
60. Koshy B, Matilla T, Burright EN et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Gen 1996 ; 5:1311-8.
61. Burke JR, Enghild JJ, Martin ME et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996 ; 2:347-50.
62. Goldberg YP, Nicholson DW, Rasper DM et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 1996 ; 13:442-9.
63. Mandel JL, Breaking the rule of three. Nature 1997 ; 386:767-9.
64. Lalioti MD, Scott HS, Buresi C et al. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 1997 ; 386: 847-51.
65. Lafrenière RG, Rochefort DL, Chretien N et al. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nature Genet 1997 ; 15:298-302.
66. Virtaneva K, D'Amato E, Miao J et al. Unstable minisatellite expansion causing recessively inherited myodonus epilepsy, EPM1. Nature Genet 1997 ; 15:393-6.
67. Burright EN, Clark HB, Servadio A et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995 ; 82:937-48.
68. Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nature Genet 1997 ; 15:197-200.
69. Monckton DG, Coolbaugh MI, Ashizawa KT, Siciliano MJ, Caskey CT. Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nature Genet 1997 ; 15:193-6.
70. David G, Abbas N, Stevanin G et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet 1997 ; 17:65-70.